Showing results (101-110 of 19,868) with videos related to

Sort By:
Pageof 1,987
Annals of Surgery|October 1, 1996
Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trialsH Buchwald, C T Campos, J R Boen, et al.
Cancer Treatment Reports|March 1, 1984
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic resultsR T Chlebowski, A Brzechwa-Adjukiewicz, A Cowden, et al.
Clinical Nuclear Medicine|May 1, 1987
Exercise-induced muscle uptake of technetium-99m MDPR P du Cret, R J Boudreau, J B Block, et al.
European Journal of Clinical Investigation|December 1, 1986
Differing attitudes of industry and academia towards controlled clinical trialsA L Blum, T C Chalmers, E Deutsch, et al.
Annals of Internal Medicine|June 1, 1995
Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illnessJ P Ioannidis, J C Cappelleri, J Lau, et al.
Annals of Internal Medicine|June 15, 1993
Cognitive behavioral techniques for hypertension: are they effective?D M Eisenberg, T L Delbanco, C S Berkey, et al.
Cancer Treatment Reports|December 1, 1977
Pharmacokinetics of high-dose methotrexate with citrovorum factor rescueW H Isacoff, P F Morrison, J Aroesty, et al.
Medical and Pediatric Oncology|January 1, 1976
High dose methotrexate therapy of solid tumors: observations relating to clinical toxicityW H Isacoff, C M Townsend, F R Eiber, et al.
The American Journal of Clinical Nutrition|April 1, 1990
Fecapentaene excretion: aspects of excretion in newborn infants, children, and adult normal subjects and in adults maintained on total parenteral nutritionJ B Block, M F Dietrich, R Leake, et al.
American Journal of Clinical Oncology|April 1, 1985
Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancerR T Chlebowski, J S Chlebowski, J Herrold, et al.
Pageof 1,987